Results 81 to 90 of about 960 (168)

Prostate cancer immunotherapy

open access: yes, 2017
Rak prostate po incidenciji i mortalitetu spada među najčešće tumore u muškaraca. Usprkos nedavnim postignućima u liječenju hormonski rezistentnog raka prostate, i dalje postoji potreba istraživanja i pronalaženja lijekova koji mogu omogućiti kvalitetnu ...
Juretić, Antonio, Antonio Juretić
core  

Development of a New Diagnostic Tool (LUTS/BPH Score) for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. [PDF]

open access: yesWorld J Mens Health
Jeh SU   +32 more
europepmc   +1 more source

Repurposing Metformin in Precision Oncology: Mechanistic Insights, Biomarker-Guided Strategies, and Translational Imperatives. [PDF]

open access: yesMedicina (Kaunas)
Khan SS   +7 more
europepmc   +1 more source

<i>RAD51</i> and <i>PALB2</i> in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review). [PDF]

open access: yesInt J Oncol
Kausar MA   +10 more
europepmc   +1 more source

Efficacy, Safety and Predictive Biomarkers of Oncolytic Virus Therapy in Solid Tumors: A Systematic Review and Meta-Analysis. [PDF]

open access: yesVaccines (Basel)
El-Tanani M   +8 more
europepmc   +1 more source

Metformin Beyond Diabetes: A Precision Gerotherapeutic and Immunometabolic Adjuvant for Aging and Cancer. [PDF]

open access: yesCancers (Basel)
Rehman A   +8 more
europepmc   +1 more source

Pimozide Reprograms the Ran GTPase-SCF Axis and Matrix Remodeling Pathways in Breast, Colorectal, and Pancreatic Cancer Models. [PDF]

open access: yesCancers (Basel)
Al-Ali HAH   +9 more
europepmc   +1 more source

Evaluation of patient’s position correction with dual registration for radiotherapy of prostate cancer

open access: yes, 2019
Uvod: Rak prostate je najpogostejši rak pri moških v Evropi, in tudi v Sloveniji. Velikost varnostnega roba pri obsevanju prostate vpliva na dozo, ki jo bodo prejeli kritični organi, zato se le ta v procesu izdelave obsevalnega plana natančno določi z ...
Poljanec, Neja, Hribar, Mojca
core  

Home - About - Disclaimer - Privacy